Researchers at the Institut Pasteur in France have developed artificial "lymphoid organ-chips" that recreate much of the human immune system's response to booster vaccines. The technology, described ...
AtLP are conditions in which it is not possible to differentiate between the benign and the malignant nature of a given lymphoid infiltrate. The descriptive term AtLP may be used as an interim ...
We have begun a study of gene expression in lymphoid malignancies by constructing a specialized cDNA microarray, termed the ‘Lymphochip’, that is enriched in genes selectively expressed in ...
The study, published Oct. 25 in Nature Immunology, provides new information about lymph node-like structures called tertiary lymphoid structures. These structures, which are highly organized ...
Dr El-Sharkawi's group researches chronic lymphocytic leukemia, rare leukaemias and lymphomas as well as early phase trials and drug development. Dima El-Sharkawi was appointed as a Consultant ...
The study, published Oct. 25 in Nature Immunology, provides new information about lymph node-like structures called tertiary lymphoid structures. These structures, which are highly organized ...
It can stimulate dendritic cell maturation and T-cell infiltration. Moreover, B cells, macrophages and other immune cells may also be affected. Tertiary lymphoid structure (TLS) is a unique structure ...
It commonly affects women of African American descent. Shahid Mukhtar and his team — Bharat Mishra, Nilesh Kumar and graduate student YiFei Gou — used single-cell sequencing techniques to pinpoint CD2 ...